Table 5.
2005 estimated prevalence of illness inferred from drugs’ dispensation among 2,028,621 insured
| Morbidity categories | Crude rates (%) | Gender and age adjusted rates (%) | Published prevalence rates (%) b |
|---|---|---|---|
| Pain |
31.6 |
31.4 |
|
| Other acute upper respiratory infections |
18.1 |
18.2 |
|
| Bacterial infection or septicemia |
17.5 |
17.4 |
|
| Hypertensive disease/heart failure |
14.9 |
19.0 |
Aged 35–75: 36.7, 50.1% currently treated [35] |
| Mental disorders |
14.1 |
14.1 |
Aged 18–65: 26.0 -28.3 [36] |
| Other mental and behavioral disorders |
10.1 |
9.3 |
|
| Mood [affective] disorders |
7.5 |
8.3 |
Major depression: 2-7 [36,37] |
| Schizophrenia, schizotypal and delusional disorders |
1.7 |
1.8 |
0.2–1.3 [36,37] |
| Diseases of esophagus and peptic ulcer |
9.4 |
9.1 |
|
| Functional digestive disorders |
9.2 |
9.0 |
|
| Thrombo-embolic risk or disease |
7.9 |
7.4 |
|
| Mycosis |
7.2 |
7.1 |
|
| Hyperlipidemia |
7.3 |
10.8 |
Aged 35–75 treated: 13.5 [35] |
| Dermatitis |
6.4 |
6.3 |
|
| Other diseases of upper respiratory tract - allergy |
5.3 |
5.4 |
|
| Reactive airway disease |
5.4 |
5.6 |
Aged > 29: 5.0 [38] |
| Infections of the skin and subcutaneous tissue |
3.9 |
3.9 |
|
| Conjunctivitis |
3.2 |
3.3 |
|
| Diabetes mellitus |
3.1 |
3.8 |
Aged >19: 3.5-4.3 [39,40] |
| Gastroenteritis of presumed infectious origin |
2.8 |
2.8 |
|
| Anemia - nutritional |
2.6 |
2.5 |
|
| Inflammatory diseases of female pelvic organs |
2.5 |
2.5 |
|
| Eye inflammation |
2.1 |
2.1 |
|
| Hyperplasia of prostate |
2.2 |
5.2 |
Males > 39: 13-28 [41],a |
| Acne |
1.8 |
1.9 |
|
| Inflammatory polyarthritis and connective tissue disorders |
1.7 |
1.6 |
|
| Glaucoma |
1.6 |
2.9 |
Aged > 39: 2 [42],a |
| Osteoporosis |
1.5 |
3.3 |
Aged > 39: 13.8 [43] |
| Epilepsy |
1.3 |
1.3 |
1.0 [44],a |
| Thyroid disorders |
1.2 |
1.2 |
1.0 [45],a |
| Disorders of external ear |
1.1 |
1.1 |
|
| Hemorrhoids |
1.0 |
1.0 |
|
| Migraine |
0.99 |
0.98 |
|
| Ischemic heart disease |
0.99 |
0.89 |
|
| Malignant neoplasm |
0.74 |
0.71 |
|
| Vertigo |
0.73 |
0.70 |
|
| Parasitosis |
0.68 |
0.68 |
|
| Gout |
0.70 |
0.66 |
|
| Viral diseases |
0.61 |
0.60 |
|
| Psoriasis |
0.53 |
0.52 |
|
| Parkinson’s disease |
0.54 |
1.68 |
Aged > 59: 0.91 [46] |
| Conduction disorders and cardiac arrhythmias |
0.52 |
0.47 |
|
| Paludism |
0.29 |
0.29 |
|
| Alzheimer's disease |
0.30 |
1.26 |
Aged > 59: 4.5 [46] |
| Crohn's disease and ulcerative colitis |
0.27 |
0.26 |
0.21 [47] |
| Hemorrhagic risk or disease |
0.19 |
0.24 |
|
| Obesity |
0.22 |
0.21 |
|
| Human immunodeficiency virus [HIV] disease |
0.15 |
0.14 |
0.3 [48] |
| Transplant |
0.12 |
0.12 |
Renal grafts only ~0.04 [49],b |
| Mental and behavioral disorders due to alcohol |
0.12 |
0.12 |
|
| Other endocrine, nutritional and metabolic diseases |
0.09 |
0.09 |
|
| Anemia - others |
0.08 |
0.08 |
|
| Poisonings by drugs, medication and biological substances and toxic effects of substances chiefly nonmedicinal |
0.06 |
0.06 |
|
| Multiple sclerosis |
0.05 |
0.05 |
|
| Influenza |
0.04 |
0.04 |
|
| Hepatitis B or C |
0.03 |
0.03 |
|
| Neutropenia |
0.03 |
0.02 |
|
| Tuberculosis (active) |
0.01 |
0.01 |
0.008 [50] |
| Abuse of opioids | 0.01 | 0.01 |
aInternational data due to lack of Swiss data.
bConsidering 250 transplants per year between 1998 and 2006, and a graft half-life of 13 years.